Journey Medical Financials
| DERM Stock | USD 4.16 0.31 8.05% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | 1.55 |
|
|
Investors should never underestimate Journey Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Journey Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Journey Medical Corp.
Net Income |
|
Journey | Select Account or Indicator |
Understanding current and past Journey Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Journey Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Journey Medical's assets may result in an increase in income on the income statement.
Journey Medical Stock Summary
Journey Medical competes with Evoke Pharma, Avadel Pharmaceuticals, Aquestive Therapeutics, Cresco Labs, and Curaleaf Holdings. Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 90 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US48115J1097 |
| CUSIP | 48115J109 |
| Location | Arizona; U.S.A |
| Business Address | 9237 East Via |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | journeymedicalcorp.com |
| Phone | 480 434 6670 |
| Currency | USD - US Dollar |
Journey Medical Key Financial Ratios
| Return On Equity | -1.3 | ||||
| Profit Margin | (0.32) % | ||||
| Operating Margin | (0.20) % | ||||
| Price To Sales | 1.39 X | ||||
| Revenue | 79.18 M |
Journey Medical Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 51.9M | 97.3M | 105.2M | 76.8M | 69.2M | 65.7M | |
| Other Current Liab | 26.0M | 23.4M | 26.8M | 20.4M | 23.4M | 24.4M | |
| Net Debt | (2.8M) | (48.2M) | (9.0M) | (9.7M) | (11.2M) | (11.7M) | |
| Retained Earnings | 5.1M | (38.9M) | (68.5M) | (72.4M) | (83.2M) | (87.4M) | |
| Accounts Payable | 2.0M | 22.8M | 37.0M | 18.3M | 21.1M | 15.6M | |
| Cash | 8.2M | 49.1M | 32.0M | 27.4M | 24.7M | 23.5M | |
| Net Receivables | 23.9M | 23.1M | 28.2M | 15.2M | 17.5M | 17.6M | |
| Other Current Assets | 1.7M | 4.9M | 3.3M | 3.6M | 3.2M | 3.4M | |
| Total Liab | 41.6M | 55.2M | 88.2M | 56.5M | 50.8M | 93.1M | |
| Total Current Assets | 35.2M | 84.5M | 77.7M | 56.5M | 50.8M | 48.3M | |
| Short Term Debt | 85K | 5.4M | 3.0M | 3.1M | 3.6M | 2.6M | |
| Intangible Assets | 15.0M | 12.6M | 27.2M | 20.3M | 23.3M | 24.5M | |
| Inventory | 1.4M | 9.9M | 14.2M | 10.2M | 11.7M | 8.2M | |
| Net Invested Capital | 15.5M | 42.9M | 39.8M | 35.0M | 40.2M | 31.0M | |
| Net Working Capital | 7.2M | 32.9M | 10.8M | 14.6M | 16.8M | 15.4M |
Journey Medical Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 698K | 7.0M | 2.0M | 1.7M | 2.0M | 1.9M | |
| Total Revenue | 44.5M | 63.1M | 73.7M | 79.2M | 91.1M | 95.6M | |
| Gross Profit | 29.9M | 31.1M | 42.9M | 52.5M | 60.4M | 63.4M | |
| Operating Income | 7.9M | (25.3M) | (27.5M) | (2.1M) | (2.4M) | (2.5M) | |
| Ebit | 7.9M | (35.3M) | (27.5M) | (1.9M) | (2.2M) | (2.3M) | |
| Ebitda | 9.4M | (32.8M) | (23.2M) | 1.9M | 2.2M | 2.3M | |
| Income Before Tax | 7.2M | (42.4M) | (29.6M) | (3.6M) | (4.2M) | (4.4M) | |
| Net Income | 5.3M | (44.0M) | (29.6M) | (3.9M) | (4.4M) | (4.7M) | |
| Income Tax Expense | 1.9M | 1.6M | 63K | 221K | 198.9K | 189.0K | |
| Cost Of Revenue | 14.6M | 32.1M | 30.8M | 26.7M | 30.7M | 21.2M | |
| Tax Provision | 1.9M | 1.6M | 63K | 108K | 97.2K | 92.3K | |
| Net Interest Income | (698K) | (7.0M) | (2.0M) | (2.0M) | (1.8M) | (1.9M) |
Journey Medical Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (547K) | (8.5M) | 1.7M | 4.0M | 4.5M | 4.8M | |
| Change In Cash | 3.4M | 40.8M | (17.1M) | (4.6M) | (4.1M) | (3.9M) | |
| Free Cash Flow | 3.9M | (12.2M) | (33.5M) | 240K | 276K | 289.8K | |
| Depreciation | 1.5M | 2.6M | 4.4M | 3.9M | 4.4M | 4.7M | |
| Other Non Cash Items | 747K | 20.5M | 1.1M | 4.3M | 4.9M | 5.2M | |
| Capital Expenditures | 1.2M | 10M | 20M | 5M | 5.8M | 4.5M | |
| Net Income | 5.3M | (44.0M) | (29.6M) | (3.9M) | (4.4M) | (4.7M) | |
| End Period Cash Flow | 8.2M | 49.1M | 32.0M | 27.4M | 24.7M | 23.5M | |
| Investments | (1.2M) | (10M) | (20M) | (5M) | (4.5M) | (4.7M) |
Journey Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Journey Medical's current stock value. Our valuation model uses many indicators to compare Journey Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Journey Medical competition to find correlations between indicators driving Journey Medical's intrinsic value. More Info.Journey Medical Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Journey Medical's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Journey Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Journey Medical Corp Systematic Risk
Journey Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Journey Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Journey Medical Corp correlated with the market. If Beta is less than 0 Journey Medical generally moves in the opposite direction as compared to the market. If Journey Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Journey Medical Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Journey Medical is generally in the same direction as the market. If Beta > 1 Journey Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Journey Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Journey Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Journey Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Journey Medical January 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Journey Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Journey Medical Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Journey Medical Corp based on widely used predictive technical indicators. In general, we focus on analyzing Journey Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Journey Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 21.08 | |||
| Value At Risk | (5.30) | |||
| Potential Upside | 6.27 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share | Quarterly Revenue Growth (0.58) | Return On Assets | Return On Equity |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.